Related Experiment Videos
Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?
K A Wikenheiser1, E B Silberstein
1Department of Radiology and Medicine, University of Cincinnati Hospital, OH 45267-0577, USA.
Cleveland Clinic Journal of Medicine
|January 1, 1996
Abstract:
It is recommended that routine bone scans not be adopted for follow-up of patients with stage I-II breast cancer. Bone scintigraphy should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.